RGC
MEDP icon

Roberts, Glore & Co’s Medpace MEDP Stock Holding History

Roberts, Glore & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
3,849
+116
+3% +$53.5K 0.5% 50
2026
Q1 		$1.79M Hold
3,733
– – 0.49% 49
2025
Q4 		$2.1M Sell
3,733
-5
-0.1% -$2.84K 0.56% 42
2025
Q3 		$1.92M Sell
3,738
-653
-15% -$285K 0.53% 48
2025
Q2 		$1.38M Buy
4,391
+140
+3% +$42K 0.4% 63
2025
Q1 		$1.3M Buy
4,251
+90
+2% +$30.3K 0.4% 63
2024
Q4 		$1.38M Buy
4,161
+80
+2% +$27.1K 0.41% 63
2024
Q3 		$1.36M Sell
4,081
-25
-0.6% -$9.5K 0.39% 65
2024
Q2 		$1.69M Sell
4,106
-656
-14% -$260K 0.51% 53
2024
Q1 		$1.92M Sell
4,762
-668
-12% -$235K 0.58% 47
2023
Q4 		$1.66M Sell
5,430
-422
-7% -$114K 0.52% 51
2023
Q3 		$1.42M Hold
5,852
– – 0.47% 58
2023
Q2 		$1.41M Buy
5,852
+45
+0.8% +$9.35K 0.45% 57
2023
Q1 		$1.09M Sell
5,807
-85
-1% -$17.6K 0.37% 70
2022
Q4 		$1.25M Sell
5,892
-441
-7% -$88.1K 0.43% 58
2022
Q3 		$995K Sell
6,333
-40
-0.6% -$6.38K 0.36% 69
2022
Q2 		$954K Buy
6,373
+4,103
+181% +$594K 0.32% 76
2022
Q1 		$371K Buy
+2,270
New +$374K 0.11% 148

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Roberts, Glore & Co's MEDP Position: Q2 2026 in Review

Roberts, Glore & Co increased its Medpace (MEDP) stake by 3.1% in Q2 2026, buying an estimated $53.5K and bringing the position to 3,849 shares worth $2.04M. The position accounts for 0.5% of the portfolio, ranked #50.

Roberts, Glore & Co first reported a position in MEDP in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.1M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Roberts, Glore & Co held 3,849 shares of Medpace worth $2.04M as of Q2 2026.
  • Roberts, Glore & Co bought 116 Medpace shares in Q2 2026, an estimated $53.5K.
  • Medpace made up 0.5% of Roberts, Glore & Co's portfolio in Q2 2026, its #50 holding.
  • Roberts, Glore & Co first reported a position in Medpace in Q1 2022 and has held it in 18 quarters since.
  • Roberts, Glore & Co's Medpace position peaked at $2.1M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.